Hepion Pharmaceuticals【HEPA】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.499899

買値

0.485

売値

0.50

出来高

13,492

0.48 日の範囲 0.51

0.4777 52 週間の範囲 3.72

時価総額

3.478M

前日終値

0.49

始値

0.51

時刻

0.49

最終取引時間

05:38:47

財務取引量

US$ 6,775

VWAP

0.502164

平均取引量 (3 か月)

45,285

発行済株式数

6,958,371

配当利回り

PER

-0.07

1 株当たり利益 (EPS)

-7.03

歳入

純利益

-48.93M

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.hepion.com

本社

Wilmington, Delaware, USA

設立

Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.49. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.4777 to US$ 3.72.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$3.41 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.07.

Form 8-K - Current report

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

Form 425 - Prospectuses and communications, business combinations

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.080101	-13.8105172414	0.58	0.599	0.4801	29376	0.52184412	CS
4	-0.190101	-27.5508695652	0.69	0.715	0.4777	28683	0.59097191	CS
12	-0.220101	-30.5695833333	0.72	0.89	0.4777	45285	0.68728092	CS
26	-0.496001	-49.8042976202	0.9959	1.12	0.4777	98906	0.79342626	CS
52	-2.720101	-84.4751863354	3.22	3.72	0.4777	79216	1.27070879	CS
156	-26.300101	-98.1347052239	26.8	27.2	0.4777	222765	14.00649807	CS
260	-99.700101	-99.5010988024	100.2	150	0.4777	905610	40.96852626	CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?

The current share price of Hepion Pharmaceuticals is US$ 0.499899

How many Hepion Pharmaceuticals shares are in issue?

Hepion Pharmaceuticals has 6,958,371 shares in issue

What is the market cap of Hepion Pharmaceuticals?

The market capitalisation of Hepion Pharmaceuticals is USD 3.41M

What is the 1 year trading range for Hepion Pharmaceuticals share price?

Hepion Pharmaceuticals has traded in the range of US$ 0.4777 to US$ 3.72 during the past year

What is the PE ratio of Hepion Pharmaceuticals?

The price to earnings ratio of Hepion Pharmaceuticals is -0.07

What is the reporting currency for Hepion Pharmaceuticals?

Hepion Pharmaceuticals reports financial results in USD

What is the latest annual profit for Hepion Pharmaceuticals?

The latest annual profit of Hepion Pharmaceuticals is USD -48.93M

What is the registered address of Hepion Pharmaceuticals?

The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Hepion Pharmaceuticals website address?

The website address for Hepion Pharmaceuticals is www.hepion.com

Which industry sector does Hepion Pharmaceuticals operate in?

Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0